Mendus
1,124 SEK -15,99 %1 investor følger denne virksomhed
Mendus is active in medical technology. The company produces therapeutic vaccines that are used in oncology. The company mainly pursues development in immunotherapy with a focus on the treatment of various serious tumors. Examples of diseases for which products are further used include kidney and liver cancer. The largest operations are in the Nordic market. The company was previously known as Immunicum and is headquartered in Stockholm.
Omsætning
3,38 mio.
EBIT %
-3.955,33 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
IMMU
Daglig lav / høj pris
0,85 / 1,148
SEK
Markedsværdi
227,83 mio. SEK
Aktieomsætning
423,72 t SEK
Volumen
408 t
Finanskalender
Delårsrapport
29.08.2023
Delårsrapport
09.11.2023
Årsrapport
14.02.2024
Viser Alle indholdstyper